| Log Type | Authored on | Log Node | Authored by |
|---|---|---|---|
| Newsletter opened | Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19 | Anonymous | |
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | É Amanhã! Convite Lundbeck Webinar Internacional | Anonymous | |
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter clicked | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous | |
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous |
| Log Type | Authored on | Log Node | Authored by |
|---|---|---|---|
| Newsletter opened | Dra. Deborah Dunsire (CEO Lundbeck) envia mensagem aos profissionais saúde durante a crise do COVID-19 | Anonymous | |
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | É Amanhã! Convite Lundbeck Webinar Internacional | Anonymous | |
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter clicked | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous | |
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous | ||
| Newsletter opened | Anonymous |